{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:28:20Z","timestamp":1787027300730,"version":"build-2736575974"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T00:00:00Z","timestamp":1780099200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:00:00Z","timestamp":1787011200000},"content-version":"vor","delay-in-days":80,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Dental Postgraduate Research Grant","award":["UMG001E-2025"],"award-info":[{"award-number":["UMG001E-2025"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Oral Health"],"DOI":"10.1186\/s12903-026-08723-7","type":"journal-article","created":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T01:43:35Z","timestamp":1780105415000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Medical practitioners\u2019 awareness and practices regarding bisphosphonate therapy and oral health risks: a Malaysian cross\u2011sectional study"],"prefix":"10.1186","volume":"26","author":[{"given":"Fatimah","family":"Che Rahimi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2216-3922","authenticated-orcid":false,"given":"Jessica","family":"Francis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen Lin","family":"Chai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pauline Siew Mei","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,30]]},"reference":[{"issue":"6","key":"8723_CR1","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1111\/bcp.13867","volume":"85","author":"S Cremers","year":"2019","unstructured":"Cremers S, Drake MT, Ebetino FH, Bilezikian JP, Russell RGG. Pharmacology of bisphosphonates. Br J Clin Pharmacol. 2019;85(6):1052\u201362.","journal-title":"Br J Clin Pharmacol"},{"key":"8723_CR2","doi-asserted-by":"publisher","unstructured":"Mbese Z, Aderibigbe BA. Bisphosphonate-Based conjugates and derivatives as potential therapeutic agents in osteoporosis, bone cancer and metastatic bone cancer. Int J Mol Sci. 2021 Jun 26;22(13):6869. https:\/\/doi.org\/10.3390\/ijms22136869.","DOI":"10.3390\/ijms22136869"},{"key":"8723_CR3","doi-asserted-by":"publisher","first-page":"221","DOI":"10.13005\/bpj\/2603","volume":"16","author":"A Ruggiero","year":"2023","unstructured":"Ruggiero A, Triarico S, Romano A, Maurizi P, Attina G, Mastrangelo S. Bisphosphonates: From Pharmacology to Treatment. Biomedical Pharmacol J. 2023;16:221\u20139.","journal-title":"Biomedical Pharmacol J"},{"issue":"1","key":"8723_CR4","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1210\/edrv.19.1.0325","volume":"19","author":"H Fleisch","year":"1998","unstructured":"Fleisch H. Bisphosphonates: mechanisms of action. Endocr Rev. 1998;19(1):80\u2013100.","journal-title":"Endocr Rev"},{"issue":"4","key":"8723_CR5","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1210\/jc.2009-1947","volume":"95","author":"NB Watts","year":"2010","unstructured":"Watts NB, Diab DL. Long-term use of bisphosphonates in osteoporosis. J Clin Endocrinol Metab. 2010;95(4):1555\u201365.","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"8723_CR6","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.4065\/83.9.1032","volume":"83","author":"MT Drake","year":"2008","unstructured":"Drake MT, Clarke BL, Khosla S. Bisphosphonates: mechanism of action and role in clinical practice. Mayo Clin Proc. 2008;83(9):1032\u201345.","journal-title":"Mayo Clin Proc"},{"issue":"2","key":"8723_CR7","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1002\/jbmr.4472","volume":"37","author":"J Everts-Graber","year":"2022","unstructured":"Everts-Graber J, Lehmann D, Burkard JP, Schaller B, Gahl B, H\u00e4uselmann H, et al. Risk of Osteonecrosis of the Jaw Under Denosumab Compared to Bisphosphonates in Patients With Osteoporosis. J Bone Min Res. 2022;37(2):340\u20138.","journal-title":"J Bone Min Res"},{"issue":"9","key":"8723_CR8","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1016\/S0278-2391(03)00720-1","volume":"61","author":"RE Marx","year":"2003","unstructured":"Marx RE. Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. J Oral Maxillofac Surg. 2003;61(9):1115\u20137.","journal-title":"J Oral Maxillofac Surg"},{"issue":"5","key":"8723_CR9","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1016\/j.joms.2022.02.008","volume":"80","author":"SL Ruggiero","year":"2022","unstructured":"Ruggiero SL, Dodson TB, Aghaloo T, Carlson ER, Ward BB, Kademani D. American Association of Oral and Maxillofacial Surgeons\u2019 Position Paper on Medication-Related Osteonecrosis of the Jaws-2022 Update. J Oral Maxillofac Surg. 2022;80(5):920\u201343.","journal-title":"J Oral Maxillofac Surg"},{"issue":"10","key":"8723_CR10","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1016\/j.joms.2014.04.031","volume":"72","author":"SL Ruggiero","year":"2014","unstructured":"Ruggiero SL, Dodson TB, Fantasia J, Goodday R, Aghaloo T, Mehrotra B, et al. American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw\u20132014 update. J Oral Maxillofac Surg. 2014;72(10):1938\u201356.","journal-title":"J Oral Maxillofac Surg"},{"issue":"9","key":"8723_CR11","doi-asserted-by":"publisher","first-page":"101707","DOI":"10.1016\/j.jsps.2023.101707","volume":"31","author":"S Aljohani","year":"2023","unstructured":"Aljohani S. Awareness, perceptions and attitudes toward medication-related osteonecrosis of the jaw among physicians who treat osteoporosis. Saudi Pharm J. 2023;31(9):101707.","journal-title":"Saudi Pharm J"},{"key":"8723_CR12","doi-asserted-by":"publisher","unstructured":"Kim JW, Jeong SR, Kim SJ, Kim Y. Perceptions of medical doctors on bisphosphonate-related osteonecrosis of the jaw. BMC Oral Health. 2016 Sep 7;16(1):92.Kim J-W, Jeong S-R, Kim S-J, Kim Y. Perceptions of medical doctors on bisphosphonate-related osteonecrosis of the jaw. BMC Oral Health. 2016;16. https:\/\/doi.org\/10.1186\/s12903-016-0290-0.","DOI":"10.1186\/s12903-016-0290-0"},{"issue":"4","key":"8723_CR13","doi-asserted-by":"publisher","first-page":"279","DOI":"10.11005\/jbm.2021.28.4.279","volume":"28","author":"JW Kim","year":"2021","unstructured":"Kim JW, Kwak MK, Han JJ, Lee ST, Kim HY, Kim SH, et al. Medication Related Osteonecrosis of the Jaw: 2021 Position Statement of the Korean Society for Bone and Mineral Research and the Korean Association of Oral and Maxillofacial Surgeons. J Bone Metab. 2021;28(4):279\u201396.","journal-title":"J Bone Metab"},{"issue":"1","key":"8723_CR14","doi-asserted-by":"publisher","first-page":"e71","DOI":"10.4317\/medoral.23191","volume":"25","author":"A Eguia","year":"2020","unstructured":"Eguia A, Bag\u00e1n-Deb\u00f3n L, Cardona F. Review and update on drugs related to the development of osteonecrosis of the jaw. Med Oral Patol Oral Cir Bucal. 2020;25(1):e71\u201383.","journal-title":"Med Oral Patol Oral Cir Bucal"},{"issue":"10","key":"8723_CR15","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1007\/s00198-023-06818-3","volume":"34","author":"FC Liu","year":"2023","unstructured":"Liu FC, Luk KC, Chen YC. Risk comparison of osteonecrosis of the jaw in osteoporotic patients treated with bisphosphonates vs. denosumab: a multi-institutional retrospective cohort study in Taiwan. Osteoporos Int. 2023;34(10):1729\u201337.","journal-title":"Osteoporos Int"},{"key":"8723_CR16","doi-asserted-by":"publisher","unstructured":"He L, Sun X, Liu Z, Qiu Y, Niu Y. Pathogenesis and multidisciplinary management of medication-related osteonecrosis of the jaw. Int J Oral Sci. 2020;12(1):30. https:\/\/doi.org\/10.1038\/s41368-020-00093-2.","DOI":"10.1038\/s41368-020-00093-2"},{"issue":"1","key":"8723_CR17","first-page":"58","volume":"17","author":"CL Gregson","year":"2022","unstructured":"Gregson CL, Armstrong DJ, Bowden J, Cooper C, Edwards J, Gittoes NJL, et al. UK Clinical Guideline for the Prevention and Treatment of Osteoporosis. NOGG. 2022;17(1):58.","journal-title":"NOGG"},{"key":"8723_CR18","unstructured":"Scottish Dental Clinical Effectiveness Programme (SDCEP). Oral Health Management of Patients at Risk of Medication-related Osteonecrosis of the Jaw. Glasgow: SDCEP; 2017."},{"issue":"4","key":"8723_CR19","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.identj.2020.12.005","volume":"71","author":"M Yamori","year":"2021","unstructured":"Yamori M, Tamura M, Mikami M, Mori T, Noi M, Machida Y, et al. Differences in the Knowledge and Experience of Physicians and Dentists About Medication-Related Osteonecrosis of the Jaw in Osteoporotic Patients. Int Dent J. 2021;71(4):336\u201342.","journal-title":"Int Dent J"},{"key":"8723_CR20","doi-asserted-by":"publisher","unstructured":"Kazmi SMR, Siddiqui HK, Khan FR, Khan SRA. Knowledge, attitudes and practices of physicians and dentists on medication-related osteonecrosis of the jaw: a cross-sectional survey. Br Dent J. 2023 May 24. https:\/\/doi.org\/10.1038\/s41415-023-5852-3.","DOI":"10.1038\/s41415-023-5852-3"},{"issue":"3","key":"8723_CR21","doi-asserted-by":"publisher","first-page":"361","DOI":"10.2174\/1574886317666220514160507","volume":"18","author":"V Priyadarshini","year":"2023","unstructured":"Priyadarshini V, Ramachandra SS, Ganganna A. Awareness and Attitude among Physicians Regarding Bisphosphonaterelated Osteonecrosis of the Jaw (BRONJ): A Cross-sectional Study. Curr Drug Saf. 2023;18(3):361\u20137.","journal-title":"Curr Drug Saf"},{"issue":"1","key":"8723_CR22","doi-asserted-by":"publisher","first-page":"e0297500","DOI":"10.1371\/journal.pone.0297500","volume":"19","author":"N Supanumpar","year":"2024","unstructured":"Supanumpar N, Pisarnturakit PP, Charatcharoenwitthaya N, Subbalekha K. Physicians\u2019 awareness of medication-related osteonecrosis of the jaw in patients with osteoporosis. PLoS ONE. 2024;19(1):e0297500.","journal-title":"PLoS ONE"},{"key":"8723_CR23","doi-asserted-by":"publisher","unstructured":"Mutlu M, Altundo\u011fan S, Kocamaz \u00d6F. Awareness and attitude towards MRONJ among physicians prescribing antiresorptive drugs: A cross-sectional study. BMC Oral Health. 2025;25(1):985. https:\/\/doi.org\/10.1186\/s12903-025-06490-5.","DOI":"10.1186\/s12903-025-06490-5"},{"issue":"1","key":"8723_CR24","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1111\/ger.12141","volume":"33","author":"DV Raj","year":"2016","unstructured":"Raj DV, Abuzar M, Borromeo GL. Bisphosphonates, healthcare professionals and oral health. Gerodontology. 2016;33(1):135\u201343.","journal-title":"Gerodontology"},{"issue":"4","key":"8723_CR25","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/S0897-1897(05)80008-4","volume":"5","author":"LL Davis","year":"1992","unstructured":"Davis LL. Instrument review: Getting the most from a panel of experts. Appl Nurs Res. 1992;5(4):194\u20137.","journal-title":"Appl Nurs Res"},{"issue":"2","key":"8723_CR26","doi-asserted-by":"publisher","first-page":"49","DOI":"10.21315\/eimj2019.11.2.6","volume":"11","author":"MSB Yusoff","year":"2019","unstructured":"Yusoff MSB. ABC of content validation and content validity index calculation. Educ Med J. 2019;11(2):49\u201354.","journal-title":"Educ Med J"},{"issue":"3","key":"8723_CR27","doi-asserted-by":"publisher","first-page":"55","DOI":"10.21315\/eimj2019.11.3.6","volume":"11","author":"MSB Yusoff","year":"2019","unstructured":"Yusoff MSB. ABC of response process validation and face validity index calculation. Educ Med J. 2019;11(3):55\u201361.","journal-title":"Educ Med J"},{"issue":"2","key":"8723_CR28","doi-asserted-by":"publisher","first-page":"e10308","DOI":"10.2196\/10308","volume":"5","author":"MF Marzuki","year":"2018","unstructured":"Marzuki MF, Yaacob NA, Yaacob NM, Translation. Cross-Cultural Adaptation, and Validation of the Malay Version of the System Usability Scale Questionnaire for the Assessment of Mobile Apps. JMIR Hum Factors. 2018;5(2):e10308.","journal-title":"JMIR Hum Factors"},{"issue":"3","key":"8723_CR29","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.sdentj.2022.01.003","volume":"34","author":"R AlRowis","year":"2022","unstructured":"AlRowis R, Aldawood A, AlOtaibi M, Alnasser E, AlSaif I, Aljaber A, et al. Medication-Related Osteonecrosis of the Jaw (MRONJ): A Review of Pathophysiology, Risk Factors, Preventive Measures and Treatment Strategies. Saudi Dent J. 2022;34(3):202\u201310.","journal-title":"Saudi Dent J"},{"key":"8723_CR30","doi-asserted-by":"publisher","first-page":"26","DOI":"10.56766\/ntms.1528563","volume":"6","author":"O Alawawda","year":"2025","unstructured":"Alawawda O, Urvas\u0131zo\u011flu G, Bayindir F. Medication-Related Osteonecrosis of the Jaw: Risk Factors, Management and Prevention in Dental Practices. New Trends Med Sci. 2025;6:26\u201336.","journal-title":"New Trends Med Sci"},{"key":"8723_CR31","doi-asserted-by":"publisher","unstructured":"Thomas JG, Ouanounou A. Medication-related osteonecrosis of the jaw: a narrative review of risk factors, diagnosis, and management. Front Oral Maxillofacial Med. 2022;5 :1\u20134. https:\/\/doi.org\/10.21037\/fomm-21-106.","DOI":"10.21037\/fomm-21-106"},{"issue":"1","key":"8723_CR32","doi-asserted-by":"publisher","first-page":"e002009","DOI":"10.1136\/bmjph-2024-002009","volume":"3","author":"AS Emuss Clark","year":"2025","unstructured":"Emuss Clark AS, Glenny AM. The issue with incidence: A scoping review of reported medication-related osteonecrosis of the jaws (MRONJ) incidence around the globe. BMJ Public Health. 2025;3(1):e002009.","journal-title":"BMJ Public Health"},{"issue":"2","key":"8723_CR33","doi-asserted-by":"publisher","first-page":"97","DOI":"10.4103\/2231-0762.178742","volume":"6","author":"D Rosella","year":"2016","unstructured":"Rosella D, Papi P, Giardino R, Cicalini E, Piccoli L, Pompa G. Medication-related osteonecrosis of the jaw: Clinical and practical guidelines. J Int Soc Prev Community Dent. 2016;6(2):97\u2013104.","journal-title":"J Int Soc Prev Community Dent"},{"issue":"4","key":"8723_CR34","first-page":"289","volume":"13","author":"AA Polymeri","year":"2015","unstructured":"Polymeri AA, Kodovazenitis GJ, Polymeris AD, Komboli M. Bisphosphonates: Clinical Applications and Adverse Events in Dentistry. Oral Health Prev Dent. 2015;13(4):289\u201399.","journal-title":"Oral Health Prev Dent"},{"key":"8723_CR35","volume-title":"The American Academy of Oral Medicine clinical practice statement: dental care for the patient on antiresorptive drug therapy","author":"J Bugueno","year":"2018","unstructured":"Bugueno J, Migliorati C. The American Academy of Oral Medicine clinical practice statement: dental care for the patient on antiresorptive drug therapy. Volume 127. Oral Medicine, Oral Pathology and Oral Radiology: Oral Surgery; 2018."},{"key":"8723_CR36","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.ctrv.2018.06.007","volume":"69","author":"S Otto","year":"2018","unstructured":"Otto S, Pautke C, Van den Wyngaert T, Niepel D, Schi\u00f8dt M. Medication-related osteonecrosis of the jaw: Prevention, diagnosis and management in patients with cancer and bone metastases. Cancer Treat Rev. 2018;69:177\u201387.","journal-title":"Cancer Treat Rev"},{"key":"8723_CR37","doi-asserted-by":"publisher","unstructured":"YonedaT, Hagino H, Sugimoto T, Ohta H, Takahashi S, Soen S et al. Antiresorptive agent-related osteonecrosis of the jaw: Position Paper 2017 of the Japanese Allied Committee on Osteonecrosis of the Jaw. J Bone Miner Metab. 2017 ;35(1):6\u201319. https:\/\/doi.org\/10.1007\/s00774-016-0810-7.","DOI":"10.1007\/s00774-016-0810-7"},{"issue":"1","key":"8723_CR38","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1186\/s40001-024-01912-6","volume":"29","author":"H Byrne","year":"2024","unstructured":"Byrne H, O\u2019Reilly S, Weadick CS, Brady P, R\u00edord\u00e1in RN. How we manage medication-related osteonecrosis of the jaw. Eur J Med Res. 2024;29(1):402.","journal-title":"Eur J Med Res"}],"container-title":["BMC Oral Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12903-026-08723-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12903-026-08723-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12903-026-08723-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:53:06Z","timestamp":1787025186000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12903-026-08723-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,30]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8723"],"URL":"https:\/\/doi.org\/10.1186\/s12903-026-08723-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7795547\/v1","asserted-by":"object"}]},"ISSN":["1472-6831"],"issn-type":[{"value":"1472-6831","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,30]]},"assertion":[{"value":"7 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study received ethical approval from the Medical Ethics Committee, Faculty of Dentistry, University of Malaya (Reference Number: DF CD 2435\/0101 (L)) and the Medical Research Ethics Committee, University Malaya Medical Centre (ID No: 20241111\u201314392). All participants were informed about the study objectives, procedures, and confidentiality of their responses. Written informed consent was obtained prior to participation.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable. This study did not involve any individual person\u2019s data, images, or identifiable information.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1497"}}